RNAC 8-K 2026-09-29

Cartesian Therapeutics, Inc. (RNAC) 8-K dated 2026-09-29 — accession 0001453687-26-000105. This URL is the filing, not the RNAC hub.

Cartesian Therapeutics, Inc. (RNAC) is a biotechnology company listed on US.

Cartesian Therapeutics, Inc. filed a 8-K on 2026-09-29. Accession 0001453687-26-000105.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RNAC revenue for 2025-12-31 was $2.8M. Net income was -$130.3M. Revenue was down 92.8% from 2024-12-31 to 2025-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.

Not investment advice. The RNAC SEC hub lists recent forms. The stock page is the research view.